Nigel Rudd

Solo Angel London, United Kingdom

About Nigel Rudd

Sir Nigel Rudd is a senior UK industrialist (former chair of Heathrow, BAA, Pendragon) and a London-based solo angel writing $100k-$250k checks at seed and Series A in medical devices and consumer wellness, with no AI flag. His operating credentials skew industrial and corporate-board rather than healthcare-specialist, and a personal check from him is most useful for founders who benefit from senior UK industrial-network credibility rather than healthcare-domain pattern recognition. Founders building UK-based medical devices with a manufacturing or industrial-supply-chain angle, consumer wellness products with retail or distribution complexity, or companies where his board-level UK corporate access adds meaningful value are the natural fit. He is the wrong audience for AI-heavy plays, biotech, software-only digital health, or anything requiring deep clinical or AI-domain expertise. The check size is meaningful and the signal value via his BGF affiliation is real for UK growth-stage credibility. With no LinkedIn link in the profile, the realistic outreach path is through BGF, the UK industrial board community, or warm introductions from senior UK corporate operators. Cold outreach is not viable. Without a published thesis, founders should treat his BGF profile as the primary intelligence source and validate activity before investing time. Best treated as a hard-to-reach angel for a narrow set of UK industrial-adjacent device founders.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.
Portfolio data coming soon. Know their portfolio? Suggest an edit →
Team information coming soon. Know the partners? Suggest an edit →

Pitch / review this investor

Have you raised from Nigel Rudd? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.